Nureca Limited (the “Company’), B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs, will open the Bid/ Issue in relation to its initial public offer of equity shares of face value of Rs. 10 each (“Equity Shares” and such initial public offer, the “Issue”) on Monday February 15, 2021. The Bid/ Issue period will close on Wednesday, February 17, 2021. The price band of the Issue has been fixed at Rs 396 to Rs 400 per Equity Share. A discount of Rs. 20 per Equity Share is being offered to Eligible Employees bidding in the Employee Reservation Portion.
The initial public offering comprises, aggregating up to Rs. 1,000.00 million (“Issue”). The issue includes a reservation aggregating to Rs. 10.00 million (constituting up to 5% of the post-issue paid up equity share capital) for purchase by eligible employees (“The Employee Reservation Portion”). The issue less the Employee Reservation Portion is hereinafter referred to as the “Net Issue”.
Bids can be made for a minimum of 35 Equity Shares and in multiples of 35 Equity Shares thereafter.
The Issue is being made through Book Building Process in terms of Rule 19(2)(b) of the Securities Contracts Regulation Rules, 1957, as amended (“SCRR”), read with Regulation 31 of the SEBI ICDR Regulations and is being made through Book Building Process, in compliance with Regulation 6(2) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended(“SEBI ICDR Regulations”), wherein at least 75% of the Net Issue shall be allotted on a proportionate basis to Qualified Institutional Buyers (“QIBs”) (the “QIB Portion”) and our Company in consultation with the BRLM allocated 60% of the QIB Portion to Anchor Investors on a discretionary basis (“Anchor Investor Portion”). One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject to valid Bids having been received from the domestic Mutual Funds at or above the Anchor Investor Allocation Price.
The IPO Committee of the Board of Directors of the Company has allotted 11,13,750 Equity Shares at a price of ₹ 400 per Equity Shares (including premium of ₹ 390 per Equity Shares) to anchor investors under the Anchor Investor Portion and raised Rs 44.55 crore on February 12, 2021. The details on the anchor allocation has been uploaded on the stock exchanges.
5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIBs (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Issue Price. If at least 75% of the Net Issue cannot be Allotted to QIBs, all the application monies will be refunded/ unblocked forthwith.
Further, not more than 15% of the Net Issue shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Net Issue shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. Further, Equity Shares shall be offered for allocation and allotment on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids received from them at or above the Issue Price. All potential Bidders (except Anchor Investors) are required to mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective ASBA accounts, and UPI ID (in case of RIBs) if applicable, in which the corresponding Bid Amounts will be blocked by the SCSBs or under the UPI Mechanism, as applicable. Anchor Investors are not permitted to participate in the Issue through the ASBA process.
The Net Proceeds from the Fresh Issue are proposed to be utilised for (i) Funding incremental working capital requirements of the Company; and (ii) General corporate purposes.
The Equity Shares offered in this Issue are proposed to be listed at both BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”, together with BSE, the “Stock Exchanges”) post the listing. For the purpose of the Issue, BSE is the Designated Stock Exchange.
ITI Capital Limited is the Book Running Lead Managers to the Issue.